A06733 Summary:

BILL NOA06733
 
SAME ASSAME AS S02763-A
 
SPONSORLavine
 
COSPNSRMcDonald, Skoufis, Steck, Hevesi, Perry, Dinowitz, Abinanti, Giglio, McDonough, Crouch, Ra, Norris, Englebright, Titone, Zebrowski, Morinello, Montesano, Colton, Jaffee, Blake, Schimminger, Glick, Gottfried, Lawrence, Rivera, D'Urso, Miller B, Benedetto, Niou, Galef
 
MLTSPNSRDavila, Raia, Simon, Wright
 
Add §280-c, Pub Health L
 
Enacts provisions governing the conduct of audits of pharmacies by pharmacy benefit managers; provides timeframes for reports, specifies documentation to be used; exempts certain investigations.
Go to top    

A06733 Actions:

BILL NOA06733
 
03/16/2017referred to health
01/03/2018referred to health
01/17/2018reported referred to codes
02/27/2018reported
03/01/2018advanced to third reading cal.694
03/05/2018passed assembly
03/05/2018delivered to senate
03/05/2018REFERRED TO HEALTH
Go to top

A06733 Committee Votes:

HEALTH Chair:Gottfried DATE:01/17/2018AYE/NAY:25/0 Action: Favorable refer to committee Codes
GottfriedAyeRaiaExcused
SchimmingerAyeMcDonoughAye
GalefAyeRaAye
DinowitzAyeWalterAye
CahillAyeGarbarinoAye
PaulinAyeByrneAye
CymbrowitzAyeNorrisAye
GuntherAye
RosenthalAye
HevesiAye
LavineAye
TitoneAye
JaffeeAye
SteckAye
AbinantiAye
BraunsteinAye
KimAye
SolagesAye
BichotteAye

CODES Chair:Lentol DATE:02/27/2018AYE/NAY:20/0 Action: Favorable
LentolAyeCurranAye
SchimmingerAyeGiglioAye
PretlowAyeMontesanoAye
CookAyeMorinelloAye
CymbrowitzAyePalumboAbsent
TitusAyeGarbarinoAye
O'DonnellAye
LavineAye
PerryAye
ZebrowskiAye
AbinantiAye
WeprinAye
MosleyAye
HevesiExcused
FahyAye
SeawrightAye

Go to top

A06733 Floor Votes:

DATE:03/05/2018Assembly Vote  YEA/NAY: 133/0
Yes
Abbate
Yes
Crouch
ER
Gunther
Yes
Mayer
Yes
Pichardo
Yes
Taylor
Yes
Abinanti
Yes
Curran
ER
Harris
Yes
McDonald
Yes
Pretlow
Yes
Thiele
Yes
Arroyo
Yes
Cusick
Yes
Hawley
ER
McDonough
Yes
Quart
Yes
Titone
Yes
Aubry
Yes
Cymbrowitz
Yes
Hevesi
Yes
Miller B
Yes
Ra
Yes
Titus
Yes
Barclay
Yes
Davila
Yes
Hikind
Yes
Miller MG
Yes
Raia
Yes
Vanel
Yes
Barnwell
Yes
De La Rosa
Yes
Hooper
Yes
Miller ML
Yes
Ramos
Yes
Walker
Yes
Barrett
Yes
DenDekker
Yes
Hunter
Yes
Montesano
ER
Richardson
Yes
Wallace
Yes
Barron
Yes
Dickens
Yes
Hyndman
Yes
Morelle
Yes
Rivera
Yes
Walsh
Yes
Benedetto
Yes
Dilan
Yes
Jaffee
Yes
Morinello
Yes
Rodriguez
Yes
Walter
Yes
Bichotte
Yes
Dinowitz
Yes
Jean-Pierre
ER
Mosley
Yes
Rosenthal D
Yes
Weinstein
Yes
Blake
Yes
DiPietro
Yes
Jenne
Yes
Murray
Yes
Rosenthal L
Yes
Weprin
Yes
Blankenbush
Yes
D'Urso
Yes
Johns
Yes
Niou
Yes
Rozic
Yes
Williams
Yes
Brabenec
Yes
Englebright
Yes
Jones
ER
Nolan
Yes
Ryan
Yes
Woerner
Yes
Braunstein
Yes
Errigo
Yes
Joyner
Yes
Norris
Yes
Santabarbara
Yes
Wright
Yes
Brindisi
Yes
Fahy
Yes
Kim
Yes
Oaks
Yes
Schimminger
Yes
Zebrowski
Yes
Bronson
Yes
Finch
Yes
Kolb
Yes
O'Donnell
Yes
Seawright
Yes
Mr. Speaker
Yes
Buchwald
Yes
Fitzpatrick
Yes
Lalor
Yes
Ortiz
Yes
Sepulveda
Yes
Butler
Yes
Friend
Yes
Lavine
Yes
Otis
Yes
Simon
Yes
Byrne
Yes
Galef
Yes
Lawrence
Yes
Palmesano
Yes
Simotas
Yes
Cahill
ER
Gantt
Yes
Lentol
Yes
Palumbo
ER
Skartados
Yes
Carroll
Yes
Garbarino
Yes
Lifton
Yes
Paulin
Yes
Skoufis
Yes
Castorina
Yes
Giglio
Yes
Lupardo
Yes
Pellegrino
Yes
Solages
Yes
Colton
Yes
Glick
Yes
Magee
Yes
Peoples-Stokes
Yes
Stec
Yes
Cook
Yes
Goodell
Yes
Magnarelli
Yes
Perry
Yes
Steck
Yes
Crespo
Yes
Gottfried
Yes
Malliotakis
Yes
Pheffer Amato
Yes
Stirpe

‡ Indicates voting via videoconference
Go to top

A06733 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6733
 
                               2017-2018 Regular Sessions
 
                   IN ASSEMBLY
 
                                     March 16, 2017
                                       ___________
 
        Introduced by M. of A. LAVINE -- read once and referred to the Committee
          on Health
 
        AN  ACT to amend the public health law, in relation to audits of pharma-
          cies
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  The  public health law is amended by adding a new section
     2  280-c to read as follows:
     3    § 280-c. Pharmacy audits by  pharmacy  benefit  managers.  1.    Defi-
     4  nitions.  As  used  in  this section, the following terms shall have the
     5  following meanings:
     6    (a) "Pharmacy benefit manager" shall  have  the  same  meaning  as  in
     7  section two hundred eighty-a of this article.
     8    (b)  "Pharmacy" shall mean a pharmacy that has contracted with a phar-
     9  macy benefit manager for the provision of pharmacy services.
    10    2. When conducting an audit of a pharmacy's records, a pharmacy  bene-
    11  fit manager shall:
    12    (a)  not conduct an on-site audit of a pharmacy at any time during the
    13  first three calendar days of a month;
    14    (b) notify the pharmacy or its contracting agent no later than fifteen
    15  days before the date of initial on-site audit. Such notification to  the
    16  pharmacy  or  its contracting agent shall be in writing delivered either
    17  (i) by mail or common carrier, return receipt requested, or  (ii)  elec-
    18  tronically with electronic receipt confirmation, addressed to the super-
    19  vising pharmacist of record and pharmacy corporate office where applica-
    20  ble, at least fifteen days before the date of an initial on-site audit;
    21    (c)  limit  the  audit  period  to twenty-four months after the date a
    22  claim is submitted to or adjudicated by the pharmacy benefit manager;
    23    (d) include in the written advance notice of an on-site audit the list
    24  of specific prescription numbers to be included in the audit that may or
    25  may not include the final two digits of the prescription numbers;
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06021-04-7

        A. 6733                             2
 
     1    (e) use the written and verifiable records of a hospital, physician or
     2  other authorized practitioner, which are transmitted  by  any  means  of
     3  communication, to validate the pharmacy records in accordance with state
     4  and federal law;
     5    (f)  limit  the  number  of  prescriptions audited to no more than one
     6  hundred randomly selected in a twelve-month period, except in  cases  of
     7  fraud;
     8    (g)  provide  the pharmacy or its contracting agent with a copy of the
     9  preliminary audit report within forty-five days after the conclusion  of
    10  the audit;
    11    (h)  be  allowed  to  conduct a follow-up audit on-site if a remote or
    12  desk audit reveals the necessity for a review of additional claims;
    13    (i) in the case of invoice audits, accept as validation invoices  from
    14  any  wholesaler  registered  with the department of education from which
    15  the pharmacy has purchased prescription drugs or, in the case of durable
    16  medical equipment or sickroom  supplies,  invoices  from  an  authorized
    17  distributor other than a wholesaler;
    18    (j)  provide the pharmacy or its contracting agent with the ability to
    19  provide  documentation  to  address  a  discrepancy  or  audit  finding,
    20  provided  that such documentation must be received by the pharmacy bene-
    21  fit manager no later than the  forty-fifth  day  after  the  preliminary
    22  audit  report was provided to the pharmacy or its contracting agent. The
    23  pharmacy benefit manager shall consider a reasonable  request  from  the
    24  pharmacy  for an extension of time to submit documentation to address or
    25  correct any findings in the report; and
    26    (k) provide the pharmacy or its contracting agent with the final audit
    27  report no later than sixty days  after  the  initial  audit  report  was
    28  provided to the pharmacy or its contracting agent.
    29    3. Any claim that was retroactively denied for a clerical error, typo-
    30  graphical  error,  scrivener's  error or computer error shall be paid if
    31  the prescription was properly and correctly dispensed, unless a  pattern
    32  of  such  errors  exists,  fraudulent  billing  is  alleged or the error
    33  results in actual financial loss to the entity.  A clerical error is  an
    34  error that does not result in actual financial harm to the covered enti-
    35  ty or consumer and does not include the dispensing of an incorrect dose,
    36  amount  or  type  of medication or dispensing a prescription drug to the
    37  wrong person.
    38    4. This section shall not apply to:
    39    (a) audits in which suspected fraudulent activity or other intentional
    40  or willful misrepresentation is evidenced by a physical  review,  review
    41  of claims data or statements, or other investigative methods; or
    42    (b) audits of claims paid for by federally funded programs; or
    43    (c) concurrent reviews or desk audits that occur within three business
    44  days of transmission of a claim and where no chargeback or recoupment is
    45  demanded.
    46    §  2.  This  act  shall take effect on the sixtieth day after it shall
    47  have become a law.
Go to top